Recombinant Human S1PR4 Protein，GST

S1PR4, or sphingosine-1-phosphate receptor 4, is a member of the sphingosine-1-phosphate receptor family, which are G protein-coupled receptors (GPCRs) that play critical roles in various physiological and pathological processes. The study of S1PR4 has gained attention due to its involvement in immune regulation, vascular biology, and neuroprotection. In particular, S1PR4 is known to modulate the trafficking and activation of various immune cells, influencing inflammatory responses and maintaining immune homeostasis. Several studies have indicated that S1PR4 can have both pro-inflammatory and anti-inflammatory effects depending on the context, making it a potential target for therapeutic interventions in autoimmune diseases, cardiovascular disorders, and cancer. The development and characterization of recombinant S1PR4 proteins have facilitated research into the receptor's structure-function relationships and its signaling pathways. Such studies are essential for elucidating the receptor's biological roles and for designing specific modulators that could lead to new treatments. The recombinant protein can be utilized in binding assays, receptor localization studies, and high-throughput screening of compounds that might affect its activity. Understanding S1PR4’s molecular mechanisms not only provides insights into its function in health and disease but also underscores its potential as a biomarker and therapeutic target in various medical conditions. Thus, the ongoing research on S1PR4 and its recombinant protein underscores its relevance in pharmacology and clinical research, paving the way for novel strategies in drug development and targeted therapies.